Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Psychiatry
•
Psychotic Disorders
•
General Psychiatry
How do you approach the use and titration of Cobenfy in patients with treatment refractory schizophrenia not responding to clozapine?
Related Questions
When do you use seizure prophylaxis in patients on clozapine?
How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?
How do you transition patients between different long-acting injectable antipsychotics?
How frequently do you recommend EKGs in pediatric patients on antipsychotics, especially in patients taking antipsychotics with more QTc risk?
How do you engage and approach a patient presenting with psychotic symptoms who has demonstrated a pattern of malingering and also has polysubstance use disorder?
When do you consider using Uzedy, the subcutaneous long-acting injectable version of risperidone?
How will the removal of the clozapine REMS requirement change your clinical practice?
How do you manage nausea side effects in patients on cariprazine?
How do you approach pharmacologic management of OCD in patients with comorbid bipolar disorder, particularly when considering SSRIs or clomipramine?
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
